These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6320206)

  • 41. A technology of preparing hepatitis A virus (HAV) from human stools.
    König J; Nĕmecek V; Dvoráková E; Seichertová A; Benda R
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):337-44. PubMed ID: 2848884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homologous interference by Newcastle disease virus. First stages of interaction of challenge virus with pre-infected cells.
    Mentkevich LM; Zhdanova LV
    Acta Virol; 1971 May; 15(3):205-9. PubMed ID: 4397340
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection.
    Gabriel P; Vallbracht A; Flehmig B
    J Med Virol; 1986 Sep; 20(1):23-31. PubMed ID: 3020167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus.
    Zhou C; Tan L; Sun Y; Qiu X; Liao Y; Song C; Liu W; Nair V; Ding C
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31174402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissociation of hepatitis A virus antigen-anti-HAV antibody complexes by 2-mercaptoethanol and dithiothreitol.
    Bradley DW; McCaustland KA; Cook EH; Fields HA; Frosner GG; Maynard JE
    J Med Virol; 1982; 9(4):311-25. PubMed ID: 6286866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations of actin-containing structures in BHK21 cells infected with Newcastle disease virus and vesicular stomatitis virus.
    Rutter G; Mannweiler K
    J Gen Virol; 1977 Nov; 37(2):233-42. PubMed ID: 200706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of glutaraldehyde on the antigenicity and infectivity of hepatitis A virus.
    Passagot J; Crance JM; Biziagos E; Laveran H; Agbalika F; Deloince R
    J Virol Methods; 1987 May; 16(1-2):21-8. PubMed ID: 3038939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acidic pH enhancement of the fusion of Newcastle disease virus with cultured cells.
    San Román K; Villar E; Muñoz-Barroso I
    Virology; 1999 Aug; 260(2):329-41. PubMed ID: 10417267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
    Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
    J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines.
    Zajac AJ; Amphlett EM; Rowlands DJ; Sangar DV
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1667-75. PubMed ID: 1649900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propagation of hepatitis A virus in human embryo fibroblasts.
    Gauss-Müller V; Frösner GG; Deinhardt F
    J Med Virol; 1981; 7(3):233-9. PubMed ID: 6270280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strain of hepatitis A virus causing cytopathic effects isolated in A549 cell line.
    Wu S; Ju LC; Shao HX; Zhang XT; Meng QH; Li XG
    Chin Med J (Engl); 1986 May; 99(5):387-92. PubMed ID: 3026743
    [No Abstract]   [Full Text] [Related]  

  • 54. Selection of temperature-sensitive mutants during persistent infection: role in maintenance of persistent Newcastle disease virus infections of L cells.
    Preble OT; Youngner JS
    J Virol; 1973 Sep; 12(3):481-91. PubMed ID: 4795831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent infection of human fibroblasts by hepatitis A virus.
    Vallbracht A; Hofmann L; Wurster KG; Flehmig B
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():609-15. PubMed ID: 6321640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.
    van Nunen AB; Pontesilli O; Uytdehaag F; Osterhaus AD; de Man RA
    Liver; 2001 Feb; 21(1):45-9. PubMed ID: 11169072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of acute hepatitis A by HAVAB-M, a direct radioimmunoassay for IgM anti-HAV.
    Decker RH; Kosakowski SM; Vanderbilt AS; Ling CM; Chairez R; Overby LR
    Am J Clin Pathol; 1981 Aug; 76(2):140-7. PubMed ID: 6267929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel Marsupial Hepatitis A Virus Corroborates Complex Evolutionary Patterns Shaping the Genus Hepatovirus.
    de Oliveira Carneiro I; Sander AL; Silva N; Moreira-Soto A; Normann A; Flehmig B; Lukashev AN; Dotzauer A; Wieseke N; Franke CR; Drexler JF
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of the chemical nature of Frp/3 cell recognition units for hepatitis A virus.
    Seganti L; Superti F; Orsi N; Gabrieli R; Divizia M; Panà A
    Med Microbiol Immunol; 1987; 176(1):21-6. PubMed ID: 3029555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates.
    Provost PJ; Conti PA; Giesa PA; Banker FS; Buynak EB; McAleer WJ; Hilleman MR
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):357-63. PubMed ID: 6302710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.